We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

58 hedge funds and large institutions have $55M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

14% more funds holding

Funds holding: 51 → 58 (+7)

12% more capital invested

Capital invested by funds: $49.1M → $55M (+$5.9M)

0.35% more ownership

Funds ownership: 41.36% → 41.71% (+0.35%)

Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
17
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$1.51M
2
Ameriprise
Ameriprise
Minnesota
+$741K
3
LPL Financial
LPL Financial
California
+$352K
4
FTUS
Flow Traders U.S.
New York
+$352K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$326K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$1.9M
2
USCWA
U.S. Capital Wealth Advisors
Texas
-$553K
3
Citadel Advisors
Citadel Advisors
Florida
-$328K
4
WBG
Wharton Business Group
Pennsylvania
-$325K
5
SWGC
Summit Wealth Group (Colorado)
Colorado
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$12.7M -$1.9M -73,855 -13%
Bank of America
2
Bank of America
North Carolina
$9.08M +$1.51M +58,538 +20%
WBG
3
Wharton Business Group
Pennsylvania
$7.15M -$325K -12,630 -4%
Raymond James Financial
4
Raymond James Financial
Florida
$3.68M -$198K -7,683 -5%
PGA
5
Portland Global Advisors
Maine
$2.7M -$77 -3 -0%
Ameriprise
6
Ameriprise
Minnesota
$2.63M +$741K +28,794 +40%
LPL Financial
7
LPL Financial
California
$1.66M +$352K +13,691 +28%
Morgan Stanley
8
Morgan Stanley
New York
$1.64M +$185K +7,201 +13%
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$1.59M -$263K -10,229 -14%
Jane Street
10
Jane Street
New York
$1.37M +$31.7K +1,232 +2%
FTUS
11
Flow Traders U.S.
New York
$1.08M +$352K +13,679 +49%
CCA
12
Clearwater Capital Advisors
Illinois
$991K -$163K -6,355 -14%
Lido Advisors
13
Lido Advisors
California
$748K +$643 +25 +0.1%
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$730K -$8.64K -336 -1%
AWM
15
Avior Wealth Management
Nebraska
$685K -$59.7K -2,321 -8%
PCA
16
Prosperity Capital Advisors
Ohio
$629K -$12.9K -502 -2%
Wells Fargo
17
Wells Fargo
California
$617K +$179K +6,974 +42%
OC
18
Opal Capital
Florida
$604K +$168K +6,550 New
Cambridge Investment Research Advisors
19
Cambridge Investment Research Advisors
Iowa
$563K -$89.3K -3,470 -14%
Jones Financial Companies
20
Jones Financial Companies
Missouri
$511K +$151K +5,870 +43%
PP
21
Prudential plc
United Kingdom
$385K -$136K -5,300 -27%
OWM
22
Opes Wealth Management
California
$378K – – –
Cetera Investment Advisers
23
Cetera Investment Advisers
Illinois
$378K +$74.4K +2,892 +25%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$331K +$326K +12,655 New
Citadel Advisors
25
Citadel Advisors
Florida
$301K -$328K -12,759 -53%
1
2 3

IDNA Hedge Fund Activity: Q4 2025 in Review

58 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2025, worth a combined $55M — up 12% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IDNA positions and 8 closed out — a net gain of 7 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was Bank of America, adding an estimated $1.51M. The largest seller was UBS Group, cutting an estimated $1.9M.

  • 58 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2025, up from 51 in Q3 2025.
  • Funds reported $55M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2025, up 12% quarter-over-quarter.
  • 15 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2025 and 8 closed out, a net change of +7 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2025 was Bank of America, an estimated $1.51M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2025 was UBS Group, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2025.